Efficacy of combined1tihypertensive treatment with amlodipin and lisinopril in metabolic syndrome

Terapevticheskii Arkhiv

Volumn 80, Issue 4, 2008, Pages 54-59

  Shevchenko, O P ^a   Praskurnichy, E A ^a   Savelyeva, S A ^a  

^a NONE

Author keywords

Amlodipine; Lisinopril; Metabolic syndrome

Indexed keywords

AMLODIPINE; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INSULIN; LISINOPRIL;

ADULT; AGED; ARTICLE; BLOOD; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG COMBINATION; DRUG EFFECT; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEART RATE; HUMAN; HYPERTENSION; MALE; METABOLIC SYNDROME X; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; AGED; AMLODIPINE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD GLUCOSE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CALCIUM CHANNEL BLOCKERS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HEART RATE; HUMANS; HYPERTENSION; INSULIN; LISINOPRIL; MALE; METABOLIC SYNDROME X; MIDDLE AGED; TREATMENT OUTCOME;

EID: 45149097727     PISSN: 00403660     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Hansson L., Zanchetti A., Carruthers S. G. et al. Effects of intensive blood-pressure lowering and low dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998; 351: 1755-1762.
2. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker as diuretic. J. A. M. A. 2002; 288: 2981-2997.
3. Dablof D., Devereux R. B., Kjeldsen et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE). Lancet 2002; 359: 995-1003.
4. Russian source
5. Russian source
6. Russian source
7. Russian source
8. Russian source
9. Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J. Hypertens. 2003; 21: 1011-1053.
10. Chobanian A. V., Barris G. L., Black H. R. et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure: the JNC 7 report. J. A. M. A. 2003; 289: 2560-2572.
11. Russian source
12. Jamerson K. A., Nwose O., Jean-Louis L. et al. Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension. Am. J. Hypertens. 2004; 17: 495-501.
13. Picca M., Bisceglia J., Zocca A. et al. Effects of enalapril and amlodipine on left ventricular hypertrophy and function in essential hypertension. Clin. Drug. Invest. 1997; 13 (suppl. 1): 29-35.
14. Rizzoni D., Muiesan M. L., Porteri E. Effects of long-term anti-hypertensive treatment with lisinopril on resistance arteries in hypertensive patients with left ventricular hypertrophy. J. Hypertens. 1997; 15 (2): 197-204.
15. Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. The EUCLID Study Group. Lancet 1997; 349: 1787-1791.
16. Russian source
17. Russian source
18. Pagani M., Lombardi F., Guzzetti S. et al. Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympathovagal interaction in man and conscious dog. Circ. Res. 1986; 59: 178-193.